1. White CE. Let IVF take its course, reconceiving procreative liberty for the twenty-first century. Women Rights Law Report 2013;35:1.
9. Lonergan P, Fair T, Corcoran D, Evans AC. Effect of culture environment on gene expression and developmental characteristics in IVF-derived embryos. Theriogenology 2006;65:137-152.
13. Mates JM, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999;32:595-603.
14. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000;18:655-673.
15. Kasparova S, Brezova V, Valko M, Horecky J, Mlynarik V, Liptaj T, et al. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem Int 2005;46:601-611.
16. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
17. Bhatnagar A, Aggarwal A. Oxidative stress: a major player in the pathophysiology of systemic lupus erythematosus. In: Laher I, editor. Systems biology of free radicals and antioxidants. Heidelberg: Springer; 2014. p. 2539-2559.
18. Berker KI, Guclu K, Demirata B, Apak R. A novel antioxidant assay of ferric reducing capacity measurement using ferrozine as the colour forming complexation reagent. Anal Methods 2010;2:1770-1778.
20. Alamdari DH, Ghayour-Mobarhan M, Tavallaie S, Parizadeh MR, Moohebati M, Ghafoori F, et al. Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Clin Biochem 2008;41:375-380.
21. Alamdari DH, Paletas K, Pegiou T, Sarigianni M, Befani C, Koliakos G. A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients. Clin Biochem 2007;40:248-254.
22. Pare WP, Glavin GB. Restraint stress in biomedical research: a review. Neurosci Biobehav Rev 1986;10:339-370.
24. Kallen B, Finnstrom O, Nygren KG, Olausson PO. In vitro fertilization in Sweden: child morbidity including cancer risk. Fertil Steril 2005;84:605-610.
25. Klemetti R, Sevon T, Gissler M, Hemminki E. Health of children born as a result of in vitro fertilization. Pediatrics 2006;118:1819-1827.
26. Cetinkaya F, Gelen SA, Kervancioglu E, Oral E. Prevalence of asthma and other allergic diseases in children born after in vitro fertilisation. Allergol Immunopathol (Madr) 2009;37:11-13.
27. Kalen B, Finnstrom O, Nygren KG, Otterblad Olausson P. Asthma in Swedish children conceived by in vitro fertilisation. Arch Dis Child 2013;98:92-96.
29. Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Cancer risk in children and young adults conceived by in vitro fertilization. Pediatrics 2010;126:270-276.
30. Kallen B, Finnstrom O, Nygren KG, Olausson PO. The link between IVF children and cancer: what do we know so far. Reprod Syst Sex Disord 2012;S5:004.
31. Williams CL, Bunch KJ, Stiller CA, Murphy MF, Botting BJ, Wallace WH, et al. Cancer risk among children born after assisted conception. N Engl J Med 2013;369:1819-1827.
34. Sakka SD, Loutradis D, Kanaka-Gantenbein C, Margeli A, Papastamataki M, Papassotiriou I, et al. Absence of insulin resistance and low-grade inflammation despite early metabolic syndrome manifestations in children born after in vitro fertilization. Fertil Steril 2010;94:1693-1699.